SAB Biotherapeutics (SABS) Financials: Revenue & Earnings

SABS price $3.14 +0.07 +2.27%

Ticker
SABS
Price
$3.14
Change
+0.07 +2.27%
Market cap ?
$285.66M
Beta ?
0.58
Sector
Healthcare
Industry
Biotechnology

Fair value

SABS fair value $291.24. Price $3.14. Price is 99% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Model uncertainty high for this stock

Compare SABS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-13—-0.27—125.00K
2026-08-06-0.28-0.28—125.00K
2026-05-12-0.35-0.20—125.00K
2026-03-09-0.46-0.16—100.00K
2025-11-14-0.21-0.59—100.00K
2025-08-07-1.09-0.82—83.33K
2025-05-09-0.56-1.00—125.00K
2025-03-28-1.23-1.16100.00K120.00K
2024-11-06-1.12-1.07-410150.00K
2024-08-08-0.79-1.13263.14K—
2024-05-20-0.54-0.98944.58K—
2024-04-01-3.38-0.62305.01K—
2023-11-13-1.00-1.001.27M11.97K
2023-08-21-1.40-1.6085.52K410.00K
2023-05-16-1.50-0.80600.00K2.54M
2023-04-14-1.56-0.042.16M6.50M
2022-11-15-1.60-0.973.59M5.90M
2022-08-10-1.10-1.306.35M10.80M
2022-05-120.20-1.2011.80M11.47M
2022-03-29-0.66-0.1160.88M60.88M
2021-11-22-0.02-0.0914.70M16.90M
2021-08-09-0.68———
2021-05-210.32———
2021-04-02-0.01———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-17Kropotova AlexandraSell473——
2026-06-25Kropotova AlexandraSell988——
2026-03-24Kropotova AlexandraSell988——
2026-02-03Sullivan Eddie JoeBuy3.00M$4.4513.35M
2026-02-03Reich Samuel JBuy4.80M$4.4521.36M
2026-02-03Bausch Christoph LawrenceBuy1.80M$4.458.01M
2026-02-03Kropotova AlexandraBuy2.40M$4.4510.68M
2026-02-03To LucyBuy2.40M$4.4510.68M
2026-01-05Jain RitaBuy240.00K$3.74897.60K
2026-01-05ZACCARDELLI DAVIDBuy240.00K$3.74897.60K
2026-01-05Jain RitaOther0——
2026-01-05ZACCARDELLI DAVIDOther0——
2025-12-16SKYLER JAY SBuy150.00K$3.99598.50K
2025-12-16Polvino William JamesBuy150.00K$3.99598.50K
2025-12-16Lucera ErickBuy150.00K$3.99598.50K
2025-12-16Ellias Helen K.Buy150.00K$3.99598.50K
2025-12-16Giberson ScottBuy150.00K$3.99598.50K
2025-12-16Link DavidBuy150.00K$3.99598.50K
2025-12-11Kropotova AlexandraSell988——
2025-09-29Moin AndrewBuy1.74M$1.753.04M
2025-09-29Moin AndrewSell17.40K$1.7530.45K
2025-09-29Sessa Capital (Master), L.P.Buy1.74M$1.753.04M
2025-09-29Sessa Capital (Master), L.P.Sell17.40K$1.7530.45K
2025-09-19Kropotova AlexandraSell1.98K——
2025-08-26Reich Samuel JBuy4.80M$2.1710.42M
2025-08-26To LucyBuy1.20M$2.172.60M
2025-08-26Kropotova AlexandraBuy2.40M$2.175.21M
2025-08-26Bausch Christoph LawrenceBuy600.00K$2.171.30M
2025-08-26Sullivan Eddie JoeBuy3.00M$2.176.51M
2025-07-22Sessa Capital (Master), L.P.Buy228.50K$175.0039.99M
2025-07-22Sessa Capital (Master), L.P.Buy228.50K$1.75399.88K
2025-07-22Sessa Capital (Master), L.P.Buy114.25K$218.7524.99M
2025-07-22Moin AndrewBuy228.50K$175.0039.99M
2025-07-22Moin AndrewBuy228.50K$1.75399.88K
2025-07-22Moin AndrewBuy114.25K$218.7524.99M
2025-03-27Kropotova AlexandraSell1.18K——
2024-12-18Kropotova AlexandraSell9.07K——
2024-11-01Ellias Helen K.Buy35.00K$3.88135.80K
2024-11-01Ellias Helen K.Buy20.00K$3.8877.60K
2024-08-12To LucyBuy125.00K$2.35293.75K
2024-07-26To LucyOther0——
2024-07-15Spragens Jeffrey GBuy20.00K$2.9058.00K
2024-07-15Polvino William JamesBuy20.00K$2.9058.00K
2024-07-15Polvino William JamesBuy13.96K$2.9040.48K
2024-07-15SKYLER JAY SBuy35.00K$2.90101.50K
2024-07-15SKYLER JAY SBuy20.00K$2.9058.00K
2024-07-15Sullivan Eddie JoeBuy46.53K$5.40251.25K
2024-07-15Sullivan Eddie JoeBuy4.45K$2.9012.90K
2024-07-15Lucera ErickBuy20.00K$2.9058.00K
2024-07-15HAMILTON CHRISTINE EBuy44.20K$5.40238.69K
2024-07-15HAMILTON CHRISTINE EBuy20.00K$2.9058.00K
2024-07-15HAMILTON CHRISTINE EBuy5.82K$5.4031.40K
2024-07-15HAMILTON CHRISTINE EBuy4.45K$2.9012.90K
2024-07-15HAMILTON CHRISTINE EBuy2.33K$2.906.75K
2024-07-15Link David CharlesBuy20.00K$2.9058.00K
2024-07-15Link David CharlesBuy9.30K$2.9026.98K
2024-07-15Reich Samuel JBuy35.70K$2.90103.53K
2024-07-15Giberson ScottBuy20.00K$2.9058.00K
2024-06-04Conley Mark WilliamSell25.00K$4.79119.75K
2024-05-03SKYLER JAY SOther0——
2024-02-21Kropotova AlexandraBuy140.00K$5.17723.80K
2024-02-21Sullivan Eddie JoeBuy190.00K$5.17982.30K
2024-02-21Bausch Christoph LawrenceBuy140.00K$5.17723.80K
2024-02-21King MichaelBuy115.00K$5.17594.55K
2024-02-21Reich Samuel JBuy434.00K$5.172.24M
2023-12-07Sullivan Eddie JoeBuy1.74K$0.881.53K
2023-11-30King MichaelBuy5.00K$0.904.50K
2023-11-29Reich Samuel JBuy11.00K$0.899.84K
2023-11-24Sessa Capital (Master), L.P.Buy4.58M$0.00458
2023-11-24Sessa Capital (Master), L.P.Buy28.38K$0.6317.88K
2023-11-24Sessa Capital (Master), L.P.Sell31.27K$0.6319.70K
2023-11-24Moin AndrewBuy4.58M$0.00458
2023-11-24Moin AndrewBuy28.38K$0.6317.88K
2023-11-24Moin AndrewSell31.27K$0.6319.70K
2023-11-24Ellias Helen K.Buy2.86M$0.00286
2023-11-24Ellias Helen K.Sell1.80K$0.631.13K
2023-11-14Ellias Helen K.Other1.20K$1,000.001.20M
2023-11-14Ellias Helen K.Other3.00K$1,000.003.00M
2023-11-14Ellias Helen K.Other2.86M$0.631.80M
2023-11-13Moin AndrewBuy13.27K$0.638.36K
2023-11-13Moin AndrewBuy13.27K$0.638.36K
2023-11-13Moin AndrewSell13.27K$1,000.0013.27M
2023-11-13Sessa Capital (Master), L.P.Buy13.27K$0.638.36K
2023-11-13Sessa Capital (Master), L.P.Sell13.27K$1,000.0013.27M
2023-11-10Moin AndrewBuy22.11K$1,000.0022.11M
2023-11-10Moin AndrewBuy8.85K$1,000.008.85M
2023-11-10Moin AndrewBuy13.27K$1,000.0013.27M
2023-11-10Sessa Capital (Master), L.P.Buy22.11K$1,000.0022.11M
2023-11-10Sessa Capital (Master), L.P.Buy8.85K$1,000.008.85M
2023-11-10Sessa Capital (Master), L.P.Buy13.27K$1,000.0013.27M
2023-10-30King MichaelBuy850.00K$0.80678.30K
2023-10-30King MichaelOther0——
2023-10-23Sessa Capital (Master), L.P.Buy16.27K$0.6310.25K
2023-10-23Sessa Capital (Master), L.P.Sell16.27K$1,000.0016.27M
2023-10-23Moin AndrewBuy16.27K$0.6310.25K
2023-10-23Moin AndrewSell16.27K$1,000.0016.27M
2023-10-02Sessa Capital (Master), L.P.Sell30.00K$1,000.0030.00M
2023-10-02Sessa Capital (Master), L.P.Sell16.27K$1,000.0016.27M
2023-10-02Sessa Capital (Master), L.P.Sell12.00K$1,000.0012.00M
2023-10-02Sessa Capital (Master), L.P.Sell2.75M$0.631.73M

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 92, holders +11 vs prior quarter. Ownership 85.89%.

HolderSharesChangeChange %Value
CALIGAN PARTNERS LP7.97M00.00%31.07M
VIVO CAPITAL, LLC7.30M-4.12M-36.08%28.47M
PERCEPTIVE ADVISORS LLC6.63M195.76K+3.04%25.85M
ADAGE CAPITAL PARTNERS GP, L.L.C.6.41M3.00M+88.09%24.98M
RA CAPITAL MANAGEMENT, L.P.4.40M00.00%17.17M
BALYASNY ASSET MANAGEMENT L.P.3.76M00.00%14.67M
BLACKROCK, INC.3.07M2.76M+917.51%11.96M
VANGUARD CAPITAL MANAGEMENT LLC2.97M479.19K+19.22%11.59M
COMMODORE CAPITAL LP2.87M-1.53M-34.79%11.19M
MILLENNIUM MANAGEMENT LLC2.75M-283.61K-9.35%10.72M
SPRUCE STREET CAPITAL LP2.20M00.00%8.57M
SESSA CAPITAL IM, L.P.2.20M00.00%8.57M
AFFINITY ASSET ADVISORS, LLC1.52M950.00K+165.22%5.95M
BOOTHBAY FUND MANAGEMENT, LLC1.48M00.00%5.78M
GEODE CAPITAL MANAGEMENT, LLC1.28M975.15K+322.86%4.98M
WOODLINE PARTNERS LP1.18M-1.67M-58.61%4.60M
ENSIGN PEAK ADVISORS, INC1.17M-202.97K-14.75%4.57M
PROPEL BIO MANAGEMENT, LLC1.08M63.79K+6.30%4.20M
SOLEUS CAPITAL MANAGEMENT, L.P.900.00K-150.00K-14.29%3.51M
SEVEN FLEET CAPITAL MANAGEMENT LP736.08K636.08K+636.08%2.87M
AMERIPRISE FINANCIAL INC611.02K-865.09K-58.61%2.38M
STATE STREET CORP530.83K456.60K+615.11%2.07M
SUSQUEHANNA INTERNATIONAL GROUP, LLP438.51K425.81K+3352.87%1.71M
DV EQUITIES, LLC400.00K400.00KNew1.56M
AWM INVESTMENT COMPANY, INC.375.00K-25.00K-6.25%1.46M

Earnings and financials

SAB Biotherapeutics, Inc. (SABS) trades at $3.14, with a market cap of $285.66M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

SAB Biotherapeutics (SABS) Financials: Revenue & Earnings

SABS$3.14+0.07 +2.27%

$285.66M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History